Novel tools for functional analysis of CD11c: Activation-specific, activation-independent, and activating antibodies

Journal of Immunoassay and Immunochemistry

Volumn 29, Issue 1, 2008, Pages 42-57

  Sadhu, Chanchal ^a   Hendrickson, Lee ^a   Dick, Ken O ^a   Potter, Tamara G ^a   Staunton, Donald E ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b Covance Laboratories ^*  (United States)

Author keywords

Agonistic; Allosteric; Antibodies; CD11c; I domain; Ligand mimetic

Indexed keywords

ANTIBODY; DIVALENT CATION; GLYCOPROTEIN P 15095; INTEGRIN;

ALLOSTERISM; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11C; CATIONS, DIVALENT; HUMANS;

EID: 37249093074     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321810701735062     Document Type: Article

References (34)

1. Shimaoka, M.; Springer, T.A. Therapeutic antagonists and conformational regulation of integrin function. Nat. Rev. Drug Discov. 2003, 2, 703-716.
2. Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110, 673-687.
3. Chen, J.; Yang, W.; Kim, M.; Carman, C.V.; Springer, T.A. Regulation of outside-in signaling and affinity by the β2 I domain of integrin αL β2. Proc. Natl. Acad. Sci. USA 2006, 103, 13062-13067.
4. Lee, J.O.; Rieu, P.; Arnaout, M.A.; Liddington, R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 1995, 80, 631-638.
5. Staunton, D.E.; Lupher, M.L.; Liddington, R.; Gallatin, W.M. Targeting integrin structure and function in disease. Adv. Immunol. 2006, 91, 111-157.
6. Li, R.; Rieu, P.; Griffith, D.L.; Scott, D.; Arnaout, M.A. Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J. Cell Biol. 1998, 143, 1523-1534.
7. Oxvig, C.; Lu, C.; Springer, T.A. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc. Natl. Acad. Sci. USA 1999, 96, 2215-2220.
8. Vorup-Jensen, T.; Ostermeier, C.; Shimaoka, M.; Hommel, U.; Springer, T.A. Structure and allosteric regulation of the alpha X β2 integrin I domain. Proc. Natl. Acad. Sci. USA 2003, 100, 1873-1878.
9. Nishida, N.; Xie, C.; Shimaoka, M.; Cheng, Y.; Walz, T.; Springer, T.A. Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. Immunity 2006, 25, 583-594.
10. Jin, M.; Andricioaei, I.; Springer, T.A. Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. Structure 2004, 12, 2137-2147.
11. Xie, C.; Shimaoka, M.; Xiao, T.; Schwab, P.; Klickstein, L.B.; Springer, T.A. The integrin alpha-subunit leg extends at a Ca2 + -dependent epitope in the thigh/genu interface upon activation. Proc. Natl. Acad. Sci. USA 2004, 101, 15422-15427.
12. Dransfield, I.; Cabanas, C.; Barrett, J.; Hogg, N. Interaction of leukocyte integrins with ligand is necessary but not sufficient for function. J. Cell Biol. 1992, 116, 1527-1535.
13. Beals, C.R.; Edwards, A.C.; Gottschalk, R.J.; Kuijpers, T.W.; Staunton, D.E. CD18 activation epitopes induced by leukocyte activation. J. Immunol. 2001, 167, 6113-6122.
14. Huang, C.; Zang, Q.; Takagi, J.; Springer, T.A. Structural and functional studies with antibodies to the integrin β2 subunit. A model for the I-like domain. J. Biol. Chem. 2000, 275, 21514-21524.
15. Keizer, G.D.; Visser, W.; Vliem, M.; Figdor, C.G. A monoclonal antibody (NKIL16) directed against a unique epitope on the alpha-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J. Immunol. 1988, 140, 1393-1400.
16. Altieri, D.C. Occupancy of CD11b/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion. J. Immunol. 1991, 147, 1891-1898.
17. Diamond, M.S.; Springer, T.A. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 1993, 120, 545-556.
18. Huang, L.; Shimaoka, M.; Rondon, I.J.; Roy, I.; Chang, Q.; Po, M.; Dransfield, D.T.; Ladner, R.C.; Edge, A.S.; Salas, A.;Wood, C.R.; Springer, T.A.; Cohen, E.H. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1. J. Leuk. Biol. 2006, 80, 905-914.
19. Shimaoka, M.; Kim, M.; Cohen, E.H.; Yang, W.; Astrof, N.; Peer, D.; Salas, A.; Ferrand, A.; Springer, T.A. AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes. Proc. Natl. Acad. Sci. USA 2006, 103, 13991-13996.
20. Tomiyama, Y.; Brojer, E.; Ruggeri, Z.M.; Shattil, S.J.; Smiltneck, J.; Gorski, J.; Kumar, A.; Kieber-Emmons, T.; Kunicki, T.J. A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb β3. J. Biol. Chem. 1992, 267, 18085-18092.
21. Weinreb, P.H.; Simon, K.J.; Rayhorn, P.; Yang, W.J.; Leone, D.R.; Dolinski, B.M.; Pearse, B.R.; Yokota, Y.; Kawakatsu, H.; Atakilit, A.; Sheppard, D.; Violette, S.M. Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J. Biol. Chem. 2004, 279, 17875-17887.
22. Hogg, N.; Takacs, L.; Palmer, D.G.; Selvendran, Y.; Allen, C. The p150,95 molecule is a marker of human mononuclear phagocytes: comparison with expression of class II molecules. Eur. J. Immunol. 1986, 16, 240-248.
23. McMichael, A.J. Leukocyte Typing III; Oxford: 1987.
24. Sadhu, C.; Ting, H.J.; Lipsky, B.; Hensley, K.; Garcia-Martinez, L.; Simon, S.I.; Staunton, D.E. CD11c/CD18: novel ligands and a role in delayed type hypersensitivity. J. Leuk. Biol. 2007, 81, 1395-1403.
25. Sadhu, C.; Masinovsky, B.; Staunton, D.E. Differential regulation of chemoattractant-stimulated β2, β3, and β7 integrin activity. J. Immunol. 1998, 160, 5622-5628.
26. Bazil, V.; Stefanova, I.; Hilgert, I.; Kristofova, H.; Vanek, S.; Horejsi, V. Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein. Folia Biol. (Praha) 1990, 36, 41-50.
27. Orchekowski, R.P.; Plescia, J.; Altieri, D.C.; Bajt, M.L. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive. J. Leuk. Biol. 2000, 68, 641-649.
28. Landis, R.C.; Bennett, R.I.; Hogg, N. A novel LFA-1 activation epitope maps to the I domain. J. Cell Biol. 1993, 120, 1519-1527.
29. Lu, C.; Shimaoka, M.; Salas, A.; Springer, T.A. The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1. J. Immunol. 2004, 173, 3972-3978.
30. Lu, C.; Shimaoka, M.; Zang, Q.; Takagi, J.; Springer, T.A. Locking in alternate conformations of the integrin αL β2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc. Natl. Acad. Sci. USA 2001, 98, 2393-2398.
31. Luk, J.; Luther, E.; Diamond, M.S.; Springer, T.S. Subunit specificity and epitope mapping of Mac-1 and p150,95 mAb using chimeric CD11b x CD11c transfectants. In Leukocyte Typing V: White Cell Differentiation Antigens; Schlossman, S.a.o. Ed.; Oxford Univ. Press: Oxford, 1995, 1599.
32. Plescia, J.; Conte, M.S.; VanMeter, G.; Ambrosini, G.; Altieri, D.C. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-αIIb β 3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J. Biol. Chem. 1998, 273, 20372-20377.
33. Li, R.; Haruta, I.; Rieu, P.; Sugimori, T.; Xiong, J.P.; Arnaout, M.A. Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b. J. Immunol. 2002, 168, 1219-1225.
34. Salas, A.; Shimaoka, M.; Phan, U.; Kim, M.; Springer, T.A. Transition from rolling to firm adhesion can be mimicked by extension of integrin αL β2 in an intermediate affinity state. J. Biol. Chem. 2006, 281, 10876-10882.